Poly‐β‐Hydroxybutyrate Nanoparticles Improve Septic Immunoparalysis and Prognosis by Energy‐Refreshing via Controlled Release of β‐Hydroxybutyrate
Small · 2026-11 · 22 (63)
DOI: 10.1002/smll.76509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 30.10.2026. Verfasst von Shanqing Xu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China. Hauptthemen laut MEDLINE: Nanoparticles, Hydroxybutyrates, Polyesters, Sepsis. Die Arbeit nennt 52 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Hunan Province.
Abstract (Originalsprache)
Sepsis‐associated immunoparalysis remains a key driver of poor clinical outcomes, yet no targeted pharmacotherapies have received clinical approval. Accumulating evidence identifies cellular metabolic dysfunction as a core pathogenic driver of this state, positioning metabolic modulation as a rational therapeutic approach. Biodegradable poly‐β‐hydroxybutyrate nanoparticles (PHB NPs) are fabricated via emulsion‐solvent evaporation to address the short in vivo half‐life and systemic adverse effects of free β‐hydroxybutyrate (BHB), leveraging the intrinsic integrated carrier‐prodrug nature of the PHB polymer.The optimized PHB NPs formulation exhibits uniform spherical morphology, extended circulation half‐life, good biocompatibility, and broad tissue biodistribution. PHB NPs attenuate immunoparalysis both in vitro and in vivo, improve survival and restore immune responsiveness to LPS rechallenge in septic mice, and preserve cognitive function in surviving animals. Mechanistically, sustained BHB release from the nanoparticles restores cellular bioenergetics in immunoparalyzed cells through the tricarboxylic acid cycle–oxidative phosphorylation (TCA–OXPHOS) axis. These protective effects are recapitulated ex vivo in immunoparalyzed peripheral blood monocytes from a small cohort of septic patients.Collectively, these data indicate that PHB NPs ameliorate sepsis‐induced immunoparalysis by restoring immune cell bioenergetics, and represent an energy‐targeted nanotherapeutic candidate for further clinical development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hunan Province Key Laboratory of Brain Homeostasis, Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
- The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China.
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, Hunan, P.R. China.
- Department of Pharmacy, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
- Hunan Key Laboratory of The Research and Development of Novel Pharmaceutical Preparations, School of Pharmaceutical Science, Changsha Medical University, Changsha, Hunan, People's Republic of China.
ORCID-Profile: Shanqing Xu, Peihe Zhang, Wenhu Zhou, Jianbin Tong
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Hunan Province
Zitieren
APA
Xu, S., Ouyang, Q., Zhang, P., Chen, H., Liu, Z., Zhou, W., & Tong, J. (2026). Poly‐β‐Hydroxybutyrate Nanoparticles Improve Septic Immunoparalysis and Prognosis by Energy‐Refreshing via Controlled Release of β‐Hydroxybutyrate. Small, 22(63). https://doi.org/10.1002/smll.76509
Vancouver
Xu S, Ouyang Q, Zhang P, Chen H, Liu Z, Zhou W, et al. Poly‐β‐Hydroxybutyrate Nanoparticles Improve Septic Immunoparalysis and Prognosis by Energy‐Refreshing via Controlled Release of β‐Hydroxybutyrate. Small. 2026;22(63). doi:10.1002/smll.76509
BibTeX
@article{Xu2026,
author = {Xu, Shanqing and Ouyang, Qin and Zhang, Peihe and Chen, Hui and Liu, Zuoliang and Zhou, Wenhu and Tong, Jianbin},
title = {Poly‐β‐Hydroxybutyrate Nanoparticles Improve Septic Immunoparalysis and Prognosis by Energy‐Refreshing via Controlled Release of β‐Hydroxybutyrate},
journal = {Small},
year = {2026},
volume = {22},
number = {63},
doi = {10.1002/smll.76509}
}
EUVIMED